Siba Raychaudhuri, MD

UC Davis, School of Medicine/ VA Medical Center, Sacramento
Davis, CA, United States

Professor, Rheumatology, Dermatology, Immunology
UC Davis School of Medicine
Chief, Rheumatology, VA Medical Center Sacramento, CA, USA

Presentation(s):

• 0586: Immune Checkpoint agonists: A New horizon for treatment of psoriatic arthritis

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): AbbVie/Abbott: Grant/Research Support (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); Novartis: Grant/Research Support (Ongoing); Sun Pharma: Advisor or Review Panel Member (Ongoing)

• 0587: Regulatory Role of IL­17 F in the Pannus Formation of Psoriatic Arthritis: A Comparative Study with IL-17A

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): AbbVie/Abbott: Grant/Research Support (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); Novartis: Grant/Research Support (Ongoing); Sun Pharma: Advisor or Review Panel Member (Ongoing)

• 1120: Synergistic Effects of IL-17F and IL-17A on Neutrophil Chemotaxis: Increased Risk of Candidiasis with Dual Blockade of IL-17A and IL17-F

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): AbbVie/Abbott: Grant/Research Support (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); Novartis: Grant/Research Support (Ongoing); Sun Pharma: Advisor or Review Panel Member (Ongoing)

• 2330: Correlation of Comorbidities with Psoriatic Arthritis Duration in Elderly Veterans - A Retrospective Cohort Study

  Tuesday, October 28, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): AbbVie/Abbott: Grant/Research Support (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); Novartis: Grant/Research Support (Ongoing); Sun Pharma: Advisor or Review Panel Member (Ongoing)